Yuil Robotics supplies bundled automation peripherals for plastic injection-molding processes — auto-feeding, take-out robots, and cooling — and adds its own articulated and collaborative robots. Its end markets split roughly into automobiles at about 32%, home appliances at about 28%, and cosmetics at about 15%, and it is broadening into food-tech and U.S.-bound industrial equipment. In February 2026 it signed a contract to supply two vacuum vapor-drying furnaces to HD Hyundai's U.S. transformer entity (about ₩5.9 billion, equal to 16.85% of recent annual revenue), widening its customer base into industrial plant equipment, while a new-plant move and headcount expansion weighed on results as near-term costs. What stands out most recently is that net cash, ample liquidity, its own robotics technology, and a portfolio expanding into U.S. industrial equipment are strengths, whereas the company is currently loss-making, so investors must confirm through quarterly results whether the expansion investment returns as revenue and profit; if order digestion lags or costs run ahead, losses could continue.

At-a-glance assessment financial health · growth · profitability · valuation

Financial healthModerate
  • The most recent full-year net result was a loss.
GrowthSlowing
  • Revenue rose 5.0% year over year, and the pace is slowing (3-year trend: rising).
  • Most recent quarter (Q1 2026) revenue was 54.7% lower than a year earlier.
ProfitabilityLoss-making
  • ROE is -27.5% (total-net basis). It is below the sector average.
  • Operating margin is -34.2%.
ValuationOvervalued
  • P/E is hard to compute here, so this is read on P/B.

Ownership & governance As of 2025-12-31

Largest shareholder Kim Dong-heon 31.27% (individual)

Controlling bloc incl. related parties 35.14%

With the controlling bloc holding 35%, the ownership structure is stable.

🔎 In-depth analysis

🏢Business
  • Yuil Robotics mainly makes automation peripherals used in plastic injection-molding processes.
  • It supplies, as a bundle, equipment that feeds raw material into the injection machine (auto-feeding), removes finished parts (take-out robots), and cools the mold (cooling).
  • To this it adds its own in-house articulated industrial robots and collaborative robots (robots built to work alongside people).
  • Its end markets split into automobiles at about 32%, home appliances at about 28%, and cosmetics at about 15%, and it has recently been broadening into food-tech systems and U.S.-bound industrial equipment.
📈Price & chart
  • The latest close is ₩68,500 and the market cap is ₩807.0 billion.
  • The price sits below its 20-day line (₩74,405) and its 60-day line (₩88,548).
  • Trading below both the short- and medium-term moving averages, the trend is on the subdued side.
  • The RSI (a supplementary gauge that compares upward and downward force over the past 14 days on a 0–100 scale) is 41.2, a neutral level.
  • The one-month change is -18.3%, the three-month change is -16.1%, and the stock sits -54.5% below its 52-week high.
  • Its relative strength versus the KOSDAQ is 71 (on a 1–99 scale that weights recent one-year returns against the index more heavily toward the recent period; higher means stronger than the market), placing it roughly in the top 29% of all stocks by strength.
  • Over the past three months it outpaced the index by 7.5%.
  • Chart interpretation is best done alongside trading volume and disclosure dates.
📊Key metrics
  • The P/E (how many times a year's profit the share price is) cannot be calculated because the company is loss-making.
  • The P/B (how many times net assets the share price is) is 9.00x.
  • The P/S (how many times annual revenue the share price is) is a somewhat high 21.6x.
  • Profitability is negative: last year's operating margin was -34.2% and ROE (how much is earned on equity in a year) was -27.5%.
  • Financial stability, however, is not bad.
  • The current ratio (cash-like assets against debt due within a year) is an ample 239%, and net debt (total borrowings minus cash) is negative — that is, it holds more cash than debt, a net-cash position.
  • FCF yield (the ratio of cash actually earned to market cap) is -2.5%, showing an expansion phase in which cash flows out as money is spent on facilities and staff.
🚀Growth
  • Revenue growth is moderate.
  • Last year's revenue of ₩36.9 billion was up 5.0% from the prior year, and the three-year average sits at about 12%.
  • The problem is profit.
  • Last year operating profit swung from a small surplus (₩0.4 billion) to a loss (-₩12.6 billion), and the net loss widened to -₩24.7 billion.
  • Taking the company's explanation and disclosures together, the key driver was one-off costs from the move to the new Cheongna plant and the expansion of manufacturing and R&D staff to build capacity, which sharply raised costs.
  • The first quarter of this year was also weak, with revenue of ₩4.6 billion (-54.7%) and a net loss of -₩8.0 billion.
  • Future profit hinges on the new plant's utilization and the pace of order digestion, and no confirmed full-year target announced by the company has been verified.
📰Recent news & filings
  • Two threads sit at the center of the recent story.
  • One is U.S.-bound industrial-equipment orders.
  • In February 2026 the company signed a contract to supply two vacuum vapor-drying furnaces (units 4 and 5) to HD Hyundai's U.S. transformer entity, worth about ₩5.9 billion, equal to 16.85% of recent annual revenue — a case of broadening its customer base beyond robots and injection into industrial plant equipment.
  • The other is expansion investment: the new-plant move and headcount buildup were booked as near-term costs and weighed on results.
  • No shareholder-return disclosures such as dividends or treasury stock have been confirmed.
🧭Bottom line
  • The strengths and weaknesses are distinct.
  • The strengths are net cash and ample liquidity, its own robotics and automation technology, and an end-market portfolio widening even into U.S. industrial equipment.
  • The weakness is the fact that it is currently loss-making.
  • With losses large last year and in the first quarter of this year, investors must confirm through actual quarterly results whether the expansion investment returns as revenue and profit.
  • If new-plant utilization rises and orders are recognized as revenue, the direction of profit could turn.
  • Conversely, if order digestion lags or costs keep running ahead, losses could persist.
  • In short, 'the speed at which expansion converts into results' is the key yardstick for this company.

🔎 Valuation vs peers Inconclusive

Domestically listed robotics and automation companies (compared by P/B rather than P/E, given the loss-making period).

PeerP/EP/BROE
Doosan Robotics0.00x13.09x-15.92%
Yujin Robot0.00x15.88x-24.32%

Because the company is loss-making, the P/E cannot be calculated, so it is impossible to call the stock cheap or expensive on an earnings basis. Looked at by P/B instead, its 8.9x is lower than the robotics cohort (Doosan Robotics 15.49x, Yujin Robot 18.0x). However, all three are loss-making, so the net-asset premium is a value carrying growth expectations. The P/S of 21.6x is high relative to revenue. Whether the current valuation succeeds hinges on whether the expansion investment converts into actual profit, so until profit is confirmed it is reasonable to hold judgment.

₩68,500 +7.54%
Market cap $534.9M

Price history Close · MA20 · MA60

Close MA20MA60

The latest close is ₩68,500 and the market capitalization is ₩807.0 billion. The price sits below its 20-day moving average (₩74,405) and below its 60-day moving average (₩88,548). It is under both its short- and medium-term moving averages, so the trend looks subdued. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 41.2, a neutral level. The one-month change is -18.3%, the three-month change is -16.1%, and the position relative to the 52-week high is -54.5%. Relative strength versus the KOSDAQ is 71 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 71% of all stocks. Over the past three months it outpaced the index by 7.5%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.

Relative performance stock vs index · start = 100

71Relative strength vs KOSDAQ1–99 · last 12 months’ return vs the index, recency-weighted · higher = stronger than the marketTop 29% strength

Excess return vs index · 3M +7.46% / 6M +2.71% / 12M -10.42%

StockKOSDAQ

Key metrics vs sector median

Valuation

P/E (trailing)
P/B9.00x
P/S21.87x
EPS₩-2,094
BPS (book value/share)₩7,614
Dividend yield
DPS

A net loss makes the P/E an unreliable valuation gauge. The P/B of 9.00x is above the sector median (6.92x).

Enterprise value (EV)

Net debt-$36,714
EV (enterprise value)$529.4M
EV/Sales21.64x
FCF (free cash flow)-$13.0M
FCF yield-2.45%

EV = market cap + net debt. It reflects cash and debt, so it captures the real cost of the whole business that market cap alone misses; lower multiples are cheaper relative to earnings or sales.

Profitability & financials

ROE-27.50%
Operating margin-34.19%
Net margin-66.82%
Debt ratio120.64%
Payout ratio

The operating margin is -34.2%. The debt ratio is 120.6%, so the financial structure is moderate.

Growth FY2025 · annual report (separate)

Item202320242025YoY
Revenue$19.5M$23.3M$24.5M+4.97% ↓ slower
Operating profit-$4.3M$261,812-$8.4M-3294.86%
Net profit-$4.3M-$6.0M-$16.4M
5-year20212022202320242025
Revenue$23.2M$25.5M$19.5M$23.3M$24.5M
Operating profit$2.1M-$2.0M-$4.3M$261,812-$8.4M
Net profit$2.6M-$1.5M-$4.3M-$6.0M-$16.4M
Revenue CAGR4-yr avg 1.35%

Revenue rose 5.0% year over year (2023 ₩29.5 billion → 2024 ₩35.2 billion → 2025 ₩36.9 billion), and the three-year trend is 'rising'. That said, the pace of growth slowed from the prior year. Operating profit fell 3294.9% year over year. Over the 5 years on record, revenue compound annual growth (CAGR) is 1.4%. The two-year revenue CAGR is 11.9%. In the most recent quarter (Q1 2026), revenue was 54.7% lower than the same period a year earlier.

Latest quarterly results Q1 2026 · vs year-ago

Revenue$3.0M
Revenue YoY-54.74%
Operating profit-$2.7M
Op. profit YoY-1044.56%
Net profit-$5.3M
Net profit YoY

Technical indicators

RSI (14)41.2
MA20₩74,405
MA60₩88,548
1-month-18.26%
3-month-16.05%
vs 52-wk high-54.55%

What stands out

Points to watch

  • The most recent full year was a loss, so it is worth checking whether profitability recovers.
  • Revenue rose 5.0% year over year, and the pace is slowing (3-year trend: rising).
  • The price is high versus peers, so expectations already appear priced in.

Recent news & events searched · sourced

Figure cross-check computed ↔ external

MetricComputedExternalStatusSource
2025 revenue (separate basis)369.2369.2Confirmedlink
U.S.-bound supply-contract amount / share of revenueapprox. 59 / 16.85%59.26 / revenue 16.85%Confirmedlink
P/B8.9xUnverifiedlink

Recent filings

📖 Plain-language glossary — expand if you are new to this
P/E
How many times a year's net profit the price is worth (lower is cheaper relative to earnings). The P/E here is on trailing (last full-year) results; for companies whose earnings swing fast (memory chips and other cyclicals/high-growth), a forward P/E on this year's expected earnings is more accurate.
P/B
Price relative to net assets (equity). Around 1x means it trades near book value; below 1x means below book.
P/S
Price relative to a year's revenue — useful for growth companies with thin earnings.
Net debt / EV
Net debt = interest-bearing debt − cash. Negative means more cash than debt (net cash). EV (enterprise value) = market cap + net debt, closer to what it would cost to buy the whole business.
EV/EBIT · EV/EBITDA · EV/Sales
Enterprise value against operating profit (EBIT), EBITDA, or revenue. Unlike P/E these reflect debt and cash; lower is cheaper relative to earnings power or sales.
FCF / FCF yield
Free cash flow = operating cash − capex, the cash actually left over. FCF yield = FCF ÷ market cap; higher means more cash generated per unit of market value.
Intrinsic value (DCF)
Future free cash flow (or, for some capex-heavy but profitable names, forecast earnings) discounted to today to estimate per-share value. Because it shifts a lot with the discount-rate and growth assumptions, it is shown as a bear/base/bull range, and the basis and assumptions are disclosed in one line beneath it.
ROE
How much profit the company earns in a year on its equity (%). Higher means better returns on capital.
EPS / BPS
Earnings per share / net assets (book value) per share.
Operating / net margin
Profit left from the core business / final profit after tax and interest, per unit of revenue.
Debt ratio
Debt relative to equity (%). Higher means more reliance on borrowing (norms vary by sector).
Current ratio
Assets convertible to cash within a year against debt due within a year. Above 100% leaves some short-term headroom.
Interest coverage
How many times operating profit covers the interest owed. Below 1x means operating profit alone struggles to cover interest.
Dividend yield / payout ratio
The year's dividend as a % of today's price / the share of earnings paid out as dividends.
Revenue CAGR
Multi-year growth expressed as a single yearly average (compound annual growth rate).
RSI (short-term signal)
Whether recent price action is overheated or beaten down. Above 70 is overbought, below 30 oversold.
MA20 / MA60 (moving averages)
The 20- and 60-day average price. Price above them signals a firmer short-term trend.
vs 52-week high
How far below the past year's peak the price sits now (%).

All figures are for reference only; how they read varies by sector and over time.

Sources: Korea FSC market-price API (data.go.kr), OpenDART, KRX/KIND — public data only.

Bong Stocks presents public-data-based information for reference only. It is not investment advice and contains no target prices, ratings, or buy/sell recommendations. Verify independently before making any decision.